Table 2.
Primary and safety outcomes of the dysphagia screening.
| Passed SLP evaluation (n = 104) | Passed RN screen (n = 673) | Passed physician screen (n = 12) | P-value | |
|---|---|---|---|---|
| Primary efficacy outcome | ||||
| Time to first antithrombotic, median min. (IQR) | 1409 (459-2540) | 774 (316-1359) | 335 (80-705) | <.01 |
| Secondary efficacy and safety outcomes | ||||
| Time to dysphagia screen, median min. (IQR) | 1330 (1009-2414) | 182 (65-503) | 38 (21-61) | <.01 |
| Placement of orogastric tube on admission, no. (%) | 32/104 (31%) | 30 (4%) | 0 (0%) | <.01 |
| Aspiration pneumonia, no. (%) | 5 (5%) | 11 (2%) | 0 (0%) | .11 |
| Length of stay, median d (IQR) | 2 (1-6) | 3 (2-6) | 6 (3-10) | <.01 |
| Death or severe disability by 90 days (mRS 5-6), no. (%) | 19/75 (25%) | 83/474 (18%) | 0/6 (0%) | .18 |
SLP denotes: speech and language pathology; RN: registered nurse; IQR: interquartile range; and mRS: Modified Rankin Scale.